Structure Therapeutics Inc - American Depositary Shares — キャッシュフロー (NASDAQ:GPCR) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -79.49 M-116.64 M-222.2 M -154.74 M 投資活動によるキャッシュフロー -268.34 M-358.91 M89.8 M -441.18 M 財務活動によるキャッシュフロー 451.53 M515.26 M762.52 M 759.97 M フリーキャッシュフロー -79.49 M-116.64 M-225.81 M -159.22 M

ニュース

LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?

Can EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?

LLY Reports Third Phase III Win for Next-Generation Obesity Drug

Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story?

Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

NVO Rallies 21% in a Month: How Should Investors Play the Stock?

LLY Stock Pops 16% After Beat-and-Raise Q1: Buy, Hold or Take Profits?

Lilly's Oral GLP-1 Pill Foundayo Starts Strong in Oral Obesity Market

Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?

Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market - TipRanks.com

LLY's Oral GLP-1 Pill Foundayo Shows Heart Benefits in Diabetes Study